Primary Investigator: Kul Aggarwal, MD
Study Coordinator: Alisa Lau-Sieckman, RN
Status: Closed to enrollment; follow-up continues
Study Title: A multicenter, double-blind, randomized study to establish the clinical benefit and safety of Vytorin vs Simvastatin monotherapy in high risk subjects presenting with acute coronary syndrome.
Purpose: The purpose of this study is to compare two drugs, ezetimibe/simvastatin combination and simvastatin alone in patients who have had a recent heart attack or unstable chest pain. Patients will be followed to see if there is a difference in future cardiac events depending on which drug they are randomized to.
Call Alisa Lau-Sieckman (beeper 573-443-9259) and/or the on-call research nurse (on-call beeper 573-499-8084) or Dr. Aggarwal if subject is admitted to the hospital or for any questions regarding study medication.